Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vibeke Strand

Showing results (401-410 of 436) with videos related to

Pageof 44
Sort By:
Current Respiratory Medicine Reviews|November 17, 2015
Patient Perspectives in OMERACT Provide an Anchor for Future Metric Development and Improved Approaches to Healthcare Delivery in Connective Tissue Disease Related Interstitial Lung Disease (CTD-ILD)Shikha Mittoo, Sid Frankel, Daphne LeSage, et al.
The Journal of Rheumatology|April 3, 2014
Updating the OMERACT filter: implications of filter 2.0 to select outcome instruments through assessment of "truth": content, face, and construct validityPeter Tugwell, Maarten Boers, Maria-Antonietta D'Agostino, et al.
The Journal of Rheumatology|March 4, 2014
Updating the OMERACT filter: implications for patient-reported outcomesJohn R Kirwan, Susan J Bartlett, Dorcas E Beaton, et al.
Seminars in Arthritis and Rheumatism|December 20, 2023
Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain setDiego Benavent, Loreto Carmona, Maria A Lopez-Olivo, et al.
Annals of the Rheumatic Diseases|September 11, 2016
International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trialsAna-Maria Orbai, Maarten de Wit, Philip Mease, et al.
The Journal of Rheumatology|August 17, 2017
Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016Esi M Morgan, Meredith P Riebschleger, Jennifer Horonjeff, et al.
The Journal of Rheumatology|April 3, 2014
Updating the OMERACT filter: discrimination and feasibilityGeorge Wells, Dorcas E Beaton, Peter Tugwell, et al.
Annals of Internal Medicine|November 6, 2002
Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trialJoel M Kremer, Mark C Genovese, Grant W Cannon, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 2, 2017
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic ArthritisLaura C Coates, Oliver FitzGerald, Joseph F Merola, et al.
The Journal of Rheumatology|January 17, 2019
Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled TrialsKathleen M Andersen, Jonathan T L Cheah, Lyn March, et al.
Pageof 44

Showing results (401-410 of 436) with videos related to

Sort By:
Pageof 44
Current Respiratory Medicine Reviews|November 17, 2015
Patient Perspectives in OMERACT Provide an Anchor for Future Metric Development and Improved Approaches to Healthcare Delivery in Connective Tissue Disease Related Interstitial Lung Disease (CTD-ILD)Shikha Mittoo, Sid Frankel, Daphne LeSage, et al.
The Journal of Rheumatology|April 3, 2014
Updating the OMERACT filter: implications of filter 2.0 to select outcome instruments through assessment of "truth": content, face, and construct validityPeter Tugwell, Maarten Boers, Maria-Antonietta D'Agostino, et al.
The Journal of Rheumatology|March 4, 2014
Updating the OMERACT filter: implications for patient-reported outcomesJohn R Kirwan, Susan J Bartlett, Dorcas E Beaton, et al.
Seminars in Arthritis and Rheumatism|December 20, 2023
Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain setDiego Benavent, Loreto Carmona, Maria A Lopez-Olivo, et al.
Annals of the Rheumatic Diseases|September 11, 2016
International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trialsAna-Maria Orbai, Maarten de Wit, Philip Mease, et al.
The Journal of Rheumatology|August 17, 2017
Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016Esi M Morgan, Meredith P Riebschleger, Jennifer Horonjeff, et al.
The Journal of Rheumatology|April 3, 2014
Updating the OMERACT filter: discrimination and feasibilityGeorge Wells, Dorcas E Beaton, Peter Tugwell, et al.
Annals of Internal Medicine|November 6, 2002
Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trialJoel M Kremer, Mark C Genovese, Grant W Cannon, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 2, 2017
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic ArthritisLaura C Coates, Oliver FitzGerald, Joseph F Merola, et al.
The Journal of Rheumatology|January 17, 2019
Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled TrialsKathleen M Andersen, Jonathan T L Cheah, Lyn March, et al.
Pageof 44